#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
John Trainer Email
CFO . NexImmune
How to contact John Trainer
Join and see John's contact info for free!Current Roles
Employees:
45Revenue:
$7MAbout
NexImmune is an emerging biopharmaceutical company advancing a new generation of immunotherapies based on our proprietary AIMâ„¢ technology. This nanotechnology platform, originally developed at Johns Hopkins University, is the foundation for an innovative approach to immunotherapy in which the body's own immune system is stimulated to orchestrate a targeted T cell response against a disease. Central to the AIM technology are artificial Antigen Presenting Cells (aAPC) that present antigens to T cells eliciting a highly targeted therapy driven by the patient's immune system. These aAPC can be rapidly engineered to elicit a specific immune attack that can be directed toward any foreign substance or cell type in a patient's body.NexImmune Address
9119 Gaither RoadGaithersburg, MD
United States